A decision-oriented framework for genomic testing across the prostate cancer continuum

This publication has 23 references indexed in Scilit:

• Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer
  Radiotherapy and Oncology, 2024
• A panel‐based mutational signature of homologous recombination deficiency associates with response to PARP inhibition in metastatic castration‐resistant prostate cancer
  The Prostate, 2024
• Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers
  JAMA Network Open, 2024
• Patient Navigation in Cancer Treatment: A Systematic Review
  Current Oncology Reports, 2024
• Patient navigation job roles by levels of experience: Workforce Development Task Group, National Navigation Roundtable
  Cancer, 2024
• Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2023
• Evaluating the sustainability of patient navigation programs in oncology by length of existence, funding, and payment model participation
  Cancer, 2022
• Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial
  Annals of Oncology, 2022
• Implementing patient navigation programs: Considerations and lessons learned from the Alliance to Advance Patient‐Centered Cancer Care
  Cancer, 2022
• A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
  European Urology, 2015